Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 55 ($0.68) and traded as high as GBX 56 ($0.69). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.68), with a volume of 70,791 shares changing hands.
Verona Pharma plc (VRP.L) Stock Performance
The company has a 50 day moving average price of GBX 55 and a 200-day moving average price of GBX 55. The company has a current ratio of 2.99, a quick ratio of 2.47 and a debt-to-equity ratio of 6.85. The company has a market cap of £228.00 million and a P/E ratio of -1.68.
Verona Pharma plc (VRP.L) Company Profile
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
Featured Articles
- Five stocks we like better than Verona Pharma plc (VRP.L)
- 3 REITs to Buy and Hold for the Long Term
- MarketBeat Week in Review – 4/22 – 4/26
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks Leading the U.S. Agriculture Comeback
- Why Invest in 5G? How to Invest in 5G Stocks
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.